WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'
Dec 18, 2021, at 03:34 am
Geneva/IBNS: The World Health Organization (WHO) on Friday announced that it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.
Novavax vaccine gets first emergency use approval in Indonesia: Statement
Nov 02, 2021, at 05:45 am
Jakarta/UNI/Sputnik: US drug maker Novavax said on Monday that the Covid-19 vaccine it jointly developed with the Serum Institute of India has received the first authorization for emergency use in Indonesia.
Novavax may get approval in two months, likely to be costlier than Covishield
Jul 01, 2021, at 02:28 am
New Delhi/IBNS: The Covovax shot developed by US vaccine-maker Novavax may be cleared for use in India between July and September, which would make it the fifth vaccine approved in the South Asian country.
Jun 18, 2021, at 12:39 am
New Delhi/IBNS: Indigenously-made Biological E's anti-Covid19 jab, expected to have an efficacy of 90 per cent could be a gamechanger in the battle against the pandemic, according to a top doctor on a government advisory panel.
Novavax COVID-19 vaccine demonstrates 90 percent overall efficacy
Jun 14, 2021, at 11:13 pm
Gaithersburg, Maryland: American biotechnology company Novavax, Inc on Monday announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100 percent protection against moderate and severe disease, 90.4 percent efficacy overall, and met the primary endpoint in its prevent-19 pivotal Phase 3 trial.
Jul 08, 2020, at 08:16 am
New York: Novavax, Inc, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, on Tuesday announced that it has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021.